Related Experiment Video
Updated: Jul 7, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Normal growth and muscle dysfunction in X-linked hypophosphatemic rickets associated with a novel mutation in the
Polyzois Makras1, Neveen A T Hamdy, Sarina G Kant
1Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
Insights
This study reports a family with X-linked hypophosphatemia (XLH) and a novel PHEX gene mutation who experienced normal growth despite delayed treatment. This challenges typical XLH growth expectations.
Area of Science:
- Genetics and Molecular Biology
- Pediatric Endocrinology
- Rare Diseases
Background:
- X-linked hypophosphatemia (XLH) is a genetic disorder causing hypophosphatemia and impaired growth.
- Early intervention is crucial for improving growth outcomes in XLH patients.
Observation:
- A family with XLH, caused by a novel PHEX gene mutation (IVS4+6T-->C), exhibited unusual clinical features over 30 years.
- Affected individuals, including a mother and two sons, displayed normal growth despite varying treatment timelines, including no treatment for the mother.
Findings:
- The novel PHEX mutation led to exon 4 skipping, resulting in a unique phenotype.
- Two sons achieved normal adult heights despite late phosphate treatment initiation and persistently low serum phosphate levels.
- Reversible proximal myopathy was observed in one son, resolving over seven years.
Implications:
- This case highlights that normal growth is achievable in XLH patients with specific PHEX mutations, even with delayed or absent treatment.
- Further research is needed to understand the genotype-phenotype correlation and the pathophysiological mechanisms underlying this atypical XLH presentation.
Context:
X-linked hypophosphatemic rickets (XLH) is characterized by hypophosphatemia and growth retardation. Early diagnosis and treatment improve growth.
Objective:
Our objective was to describe long-term observations of a family with XLH due to a novel mutation of the PHEX gene with unusual clinical features, including normal growth.
Patients:
The mother and her two sons were followed in the same institution for nearly 30 yr.
Results:
The mother had hypophosphatemia and normal height (Z score, -0.6) without ever receiving any treatment. Her two sons achieved final heights of 183.7 cm (Z score, -0.01) and 182.7 cm (Z score, -0.18), respectively, despite late initiation of treatment with phosphate and low serum phosphate levels. In addition, they had reversible proximal myopathy that took about 7 yr to resolve in one of them. Direct sequencing of the PHEX gene revealed a new splice site mutation in intron 4 of the gene (IVS4+6T-->C) resulting in skipping of exon 4.
Conclusions:
Three members of a family with XLH due to a novel mutation of the PHEX gene had a normal growth pattern despite late diagnosis and treatment of the two boys and no treatment at all of their mother. The pathophysiological basis of this phenotype-genotype association warrants further investigation.
Related Concept Videos
Sex-linked Disorders
Inborn Errors of Metabolism
Pedigree Analysis
X-linked Traits
Pleiotropy
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

